Citigroup
SGP

Citigroup’s SpyGlass Pharma SGP Stock Holding History

Citigroup’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116K Buy
+5,190
New +$113K ﹤0.01% 4594

Other funds holding SGP

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.99% 1-Year Est. Return

Citigroup's SGP Position: Q2 2026 in Review

Citigroup opened a new position in SpyGlass Pharma (SGP) in Q2 2026: 5,190 shares worth $116K. The stake represents ﹤0.01% of the portfolio and ranks #4594 among its holdings.

9 funds tracked by Wall St. Rank hold SGP as of Q2 2026.

  • Citigroup held 5,190 shares of SpyGlass Pharma worth $116K as of Q2 2026.
  • SpyGlass Pharma was a new Citigroup position in Q2 2026.
  • SpyGlass Pharma made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4594 holding.
  • 9 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.